Extended Dwell Catheter Market Size, Share, & Trends Analysis | Global | 2025-2032

Global Extended Dwell Catheter Market Report to 2032

The global extended dwell catheter market was valued at around $68 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 5.8%, reaching $100 million by 2032.

This report covers the global market for extended dwell catheters (EDCs), including regional procedure volumes, market values, unit sales, and average selling price trends.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by reduced catheter-related complications, improved first-stick success, and the use of EDCs as a lower-cost alternative to PICCs and midlines. However, competitive pressure, pricing erosion, and new PIVC and midline technologies are expected to limit stronger market value growth.

Market Overview

The global extended dwell catheter market includes catheters designed to provide longer dwell times than traditional peripheral intravenous catheters, while offering a less complex and often lower-cost alternative to PICCs and midlines.

EDCs are used for patients who require extended peripheral access but may not require full central venous access. This positions them between standard PIVCs and longer-term vascular access options such as midlines and PICCs.

ASPs remain relatively stable at the global level, although pricing conditions vary by region. North America maintains the highest ASPs due to stronger hospital budgets and preference for premium branded devices.

In other regions, pricing pressure is increasing as local distributors and regional manufacturers enter the market. Over the forecast period, ASPs are expected to decline modestly at a CAGR of around 3%, offsetting some of the market value gains created by rising unit sales.

Market Drivers

Reduced Rate of Catheter-Related Complications

Reduced catheter-related complications are a major driver of EDC adoption. Compared with traditional PIVCs, EDCs can reduce the need for additional catheter insertions and increase the rate of first-stick success.

These benefits can lower the overall rate of catheter-related complications and needlestick injuries. Both issues can be costly for hospitals and can negatively affect patient experience.

Because EDCs may reduce repeat insertions, some healthcare providers view their higher cost compared with PIVCs as justifiable in selected cases. This is expected to support EDC adoption and allow EDCs to cannibalize some demand from the PIVC market.

Lower-Cost Alternative to PICCs and Midlines

EDCs are also positioned as a lower-cost alternative to PICCs and midlines in selected patients. When longer dwell time is needed but central access is not required, EDCs can offer a practical middle-ground option.

This positioning is important because healthcare providers are often balancing catheter performance, complication risk, insertion complexity, and cost. EDCs can meet a clinical need without requiring the higher cost or more involved placement workflow associated with some longer-term access devices.

This value proposition supports EDC growth in hospitals and alternate care settings where clinicians want extended access but do not want to escalate immediately to a PICC or midline.

Improved Insertion Technology

New device designs are improving clinician confidence and supporting EDC uptake. BD's AccuCath(R) Ace, for example, includes integrated guidewire technology and is designed to improve insertion success.

Improved insertion performance is important because first-stick success can affect both patient comfort and clinical workflow. Devices that simplify insertion can reduce training burden, save time, and make EDCs more practical for broader use.

As manufacturers continue improving insertion technology and device design, EDC adoption is expected to increase. This trend is especially important following the Teleflex recall, as hospitals and clinicians reassess available extended dwell options.

Market Limiters

Competitive Pressures

Competitive pressure is a key limiter in the EDC market. Because EDCs share similarities with both PIVCs and midlines, major competitors from those larger vascular access segments could enter the EDC space.

If more large manufacturers enter the market, pricing competition could intensify. Existing EDC competitors may reduce prices to defend market share, especially in regions where hospitals are highly cost-sensitive.

This could drive ASPs downward and limit market value growth. Even if unit sales increase, price erosion may offset some of the revenue gains from broader adoption.

New PIVC and Midline Technologies

New PIVC and midline technologies also limit the EDC market. Improved safety features in the PIVC market are expected to reduce complication rates, which could reduce the need for premium-priced EDCs.

If PIVCs become safer, more stable, and easier to secure, some providers may choose to continue using PIVCs rather than switch to EDCs. This is especially relevant for patients who do not require a long dwell time.

Midlines also compete with EDCs. Products from companies such as Teleflex and Spectrum Vascular offer antimicrobial and antithrombogenic properties. These features have not yet penetrated the EDC market to the same extent, which may reduce interest in EDCs among some healthcare providers.

Modest ASP Decline

The market is also limited by expected ASP decline. While unit sales are forecast to rise, global ASPs are expected to decline modestly over the forecast period.

North America is expected to maintain higher ASPs, but many other regions are facing pressure from regional manufacturers and local distributors. These suppliers can compete aggressively on price.

This pricing trend will offset some of the value gains created by unit growth. As a result, market expansion is expected to remain steady but not as strong as the unit sales trajectory alone would suggest.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
• Device scope: The report covers extended dwell catheters, including regional procedure volumes, market values, unit sales, and ASP trends.

Markets Covered and Segmentation

Extended Dwell Catheter Market

The report covers the global extended dwell catheter market as a dedicated vascular access device segment.

Extended dwell catheters are designed to provide longer access duration than traditional PIVCs. They are often used when patients require extended peripheral access but may not need a PICC, midline, or central venous catheter.

The market is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

The report evaluates demand based on complication reduction, first-stick success, pricing trends, competitive dynamics, product recalls, clinician confidence, and competition from PIVCs and midlines.

This structure helps manufacturers, investors, and strategy teams understand how EDCs are positioned within the broader vascular access market and how they may gain share as a practical alternative between short-term PIVCs and longer-term access devices.

Competitive Analysis

In 2025, the global extended dwell catheter market underwent a notable structural shift following the recall of Teleflex's Arrow(R) Endurance(TM) device. Although the recall was formally initiated in the United States, Teleflex's guidance to distributors regarding non-U.S. distribution and mandatory product return effectively resulted in withdrawal across multiple regions.

This disruption reshaped the competitive landscape. Becton Dickinson emerged as the leading global EDC supplier, benefiting significantly from the recall-driven market shift.

BD's EDC portfolio includes AccuCath(R) and AccuCath(R) Ace, both rated for dwell times of up to 29 days. The company's flagship 5.7 cm AccuCath(R) Ace, along with shorter and more cost-effective devices that resemble conventional PIVCs, positioned BD as the dominant player in the EDC segment.

ICU Medical ranked second in the global EDC market in 2025. Its position was strengthened by the 2022 acquisition of Smiths Medical, which had previously entered the market through Access Scientific.

ICU Medical's key offering, the Powerwand(TM) EDC, is a power-injectable catheter made from ChronoFlex material with BioGUARD(TM) technology. The device is designed to simplify insertion compared with the modified Seldinger technique. Like BD, ICU Medical expanded share following the Teleflex recall.

Vygon was a growing competitor in the EDC space in 2025. Its main product, Leaderflex(R), provides dwell times up to 29 days and stands out as the only non-power-injectable device on the market. Offered in multiple lengths, including a shorter 6 cm option, Leaderflex gained attention as hospitals searched for reliable extended dwell alternatives.

Technology and Practice Trends

Extended Dwell Access

Extended dwell access is becoming more important for patients who need longer peripheral access than a standard PIVC can provide.

EDCs help fill the gap between short-term PIVCs and longer-term options such as midlines or PICCs.

First-Stick Success

Improved first-stick success is a major clinical advantage for EDCs. Fewer insertion attempts can reduce patient discomfort, save staff time, and lower the risk of needlestick injury.

This supports adoption in patients with difficult vascular access.

Integrated Guidewire Designs

Integrated guidewire technology is helping improve insertion confidence. BD's AccuCath(R) Ace is an example of a device designed to improve placement performance and simplify workflow.

These features can help differentiate EDCs from conventional PIVCs.

Power-Injectable EDCs

Power-injectable EDCs provide additional flexibility for patients who may require contrast-enhanced imaging. ICU Medical's Powerwand(TM) is one example of this category.

Power capability can support premium pricing and broader clinical use.

Recall-Driven Market Realignment

The Teleflex Arrow(R) Endurance(TM) recall reshaped the competitive environment. Hospitals and clinicians looked for alternative EDC options, creating share gains for BD, ICU Medical, and Vygon.

This shift is expected to influence purchasing patterns over the forecast period.

Pricing Pressure from Regional Suppliers

Regional manufacturers and distributors are entering the EDC space, especially outside North America. This is expected to create pricing pressure and modest ASP decline.

Suppliers will need to compete on reliability, insertion success, product design, and cost.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global extended dwell catheter market today, and how much is it expected to grow through 2032?
• How are unit sales, procedure numbers, ASPs, and market values changing over time?
• How are EDCs positioned between PIVCs, midlines, and PICCs?
• Why are EDCs gaining adoption as a lower-cost alternative to PICCs and midlines?
• How do EDCs reduce repeat insertions, complications, and needlestick injuries?
• What impact did the Teleflex Arrow(R) Endurance(TM) recall have on the competitive landscape?
• How are BD, ICU Medical, and Vygon positioned in the EDC market?
• Why are regional manufacturers and distributors creating pricing pressure?
• How will modest ASP decline affect market value growth?
• What technology trends are shaping EDC adoption, including guidewire integration and power-injectable designs?

The Global Extended Dwell Catheter Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand recall-driven market shifts, and support commercial planning in the global extended dwell catheter market.